Detalhe da pesquisa
1.
Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL.
Blood
; 140(22): 2348-2357, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35921541
2.
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma.
Blood
; 134(3): 252-262, 2019 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31118164
3.
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation.
Hematol Oncol
; 38(3): 257-265, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32356913
4.
Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer.
Breast Cancer Res Treat
; 126(2): 431-41, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21221766
5.
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial.
Blood Adv
; 4(15): 3648-3658, 2020 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32766857
6.
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy.
Breast Cancer Res Treat
; 116(2): 359-69, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18941889
7.
Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features.
Anticancer Drugs
; 20(3): 197-203, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19182679
8.
Role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapy.
Breast J
; 14(5): 435-41, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18821931
9.
Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial.
Blood Adv
; 6(18): 5356-5359, 2022 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35613463
10.
Neoadjuvant pegylated liposomal doxorubicin in combination with cisplatin and infusional fluoruracil (CCF) with and without endocrine therapy in locally advanced primary or recurrent breast cancer.
Breast
; 20(1): 34-8, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20638282
11.
Pegylated liposomal doxorubicin in combination with low-dose metronomic cyclophosphamide as preoperative treatment for patients with locally advanced breast cancer.
Breast
; 20(4): 319-23, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21397505
12.
Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer.
J Clin Oncol
; 26(30): 4899-905, 2008 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18794539
13.
Vaccine immunotherapy in breast cancer treatment: promising, but still early.
Expert Rev Anticancer Ther
; 7(9): 1225-41, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17892423